McKesson Corporation vs Zoetis Inc — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: McKesson Corporation is far larger — about 3× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| MCK | ZTS | |
|---|---|---|
Market Cap | $97.35B | $31.95B |
Sector | Health | Health |
52-Week High | $995.69 | $156.76 |
52-Week Low | $659.01 | $71.91 |
Enterprise Value | $101.98B | $39.24B |
Dividend Yield | 0.39% | 2.78% |
Trailing returns across standard periods
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →